Yang Yankun, Tian Tao, Yang Kunqi, Zhang Ying, Meng Xu, Fan Peng, Feng Lei, Mu Chaowei, Gao Linggen, Zhou Xianliang
Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China.
Department of Geriatric Cardiology, General Hospital of Chinese People's Liberation Army, Beijing 100853, China.
Int J Cardiol. 2017 Aug 15;241:64-69. doi: 10.1016/j.ijcard.2017.02.041. Epub 2017 Feb 13.
Coronary artery involvement is not a rare presentation of Takayasu arteritis (TA) and the treatment is challenging. The optimal methods of revascularization, and prognosis of treatment have not been established.
To assess the long-term outcomes of percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) in TA patients.
Patients with coronary artery involved in TA who underwent either PCI or CABG were identified between February 2003 and December 2015. The primary outcome was long-term all-cause mortality. Secondary outcomes were myocardial infarction (MI), stroke, and repeat revascularization.
Thirty-one patients were enrolled (PCI=19 vs. CABG=12). Most of them were female (25, 80.6%) and the mean age was 42.6±13.8years (16-64years). Angina pectoris was the most common initial symptom (26 cases, 83.9%) and concomitant aortic regurgitation was present in 8 (25.8%) patients. Both groups had a low rate of corticosteroids use [4/19 (21.1%) vs. 2/12 (16.7%)]. During the median follow-up of 101months (10-384months), PCI group had a significantly higher incidence of restenosis [12/19(63.2%) vs. 3/12(25%)]. Two patients with severe aortic regurgitation in PCI group suffered from cardiac death during follow-up.
Coronary artery involvement should be suspected in TA patients with angina pectoris, especially young women. PCI had a very high rate of in-stent restenosis in patients without corticosteroids and CABG may be a preferred treatment option.
冠状动脉受累在大动脉炎(TA)中并非罕见表现,其治疗具有挑战性。目前尚未确立最佳的血运重建方法及治疗预后。
评估TA患者经皮冠状动脉介入治疗(PCI)和冠状动脉旁路移植术(CABG)的长期疗效。
纳入2003年2月至2015年12月期间接受PCI或CABG治疗的TA冠状动脉受累患者。主要结局为长期全因死亡率。次要结局为心肌梗死(MI)、卒中及再次血运重建。
共纳入31例患者(PCI组19例,CABG组12例)。大多数为女性(25例,80.6%),平均年龄42.6±13.8岁(16 - 64岁)。心绞痛是最常见的初始症状(26例,83.9%),8例(25.8%)患者伴有主动脉瓣关闭不全。两组患者使用糖皮质激素的比例均较低[4/19(21.1%)对2/12(16.7%)]。在中位随访101个月(10 - 384个月)期间,PCI组再狭窄发生率显著更高[12/19(63.2%)对3/12(25%)]。PCI组2例严重主动脉瓣关闭不全患者在随访期间死于心脏疾病。
对于有心绞痛的TA患者,尤其是年轻女性,应怀疑冠状动脉受累。在未使用糖皮质激素的患者中,PCI术后支架内再狭窄率非常高,CABG可能是首选的治疗方案。